Verrica Pharmaceuticals's total assets for Q2 2025 were $39.11M, a decrease of -7.28% from the previous quarter. VRCA total liabilities were $56.59M for the fiscal quarter, a -6.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.